The Parkinson’s disease (PD) market across the seven major markets (7MM*) is forecast to grow at a compound annual growth rate (CAGR) of 7.6% from $3.4 billion in 2023 to $7.0 billion in 2033, according to GlobalData, a leading data and analytics company. GlobalData’s latest report, “Parkinson’s disease: Seven Market Drug Forecast and Market Analysis – Update,” reveals that the growth will be driven by the anticipated launches of eight late-stag…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.